Keyphrases
30-day Mortality
21%
Acute Kidney Injury
47%
Acute Lung Injury
20%
Acute Respiratory Failure
27%
Adult Intensive Care Unit
13%
Asymmetric Dimethylarginine
20%
Bioimpedance
30%
Blinded Trial
20%
Chronic Obstructive Pulmonary Disease
16%
Confidence Interval
34%
Critically Ill Patients
100%
Denmark
20%
Endothelial Damage
16%
Endotheliopathy
20%
Fluid Balance
15%
Fluid Overload
55%
Fluid Removal
34%
Fluid Status
17%
Furosemide
30%
Goal-directed Fluid
20%
Hazard Ratio
16%
High Risk
14%
Hyaluronic Acid
20%
Increased Mortality
18%
Induced Hypothermia
20%
Intensive Care
15%
Intensive Care Patients
53%
Intensive Care Unit
21%
Intensive Care Unit Patients
26%
Limits of Agreement
12%
Lung Damage
20%
Mechanical Ventilation
22%
Meta-analysis
32%
Myocardial Injury
18%
Noncardiac Surgery
20%
Organ Dysfunction
14%
PECAM-1
18%
Placebo
41%
Procalcitonin
20%
Prospective Observational Study
20%
Randomized Clinical Trial
17%
Randomized Trial
32%
Respiratory Failure
25%
Risk Prediction Model
14%
Sepsis
37%
Septic Shock
54%
Severe Sepsis
15%
Systematic Meta-analysis
21%
Thrombomodulin
23%
Ventilator
13%
Medicine and Dentistry
Acute Kidney Injury
53%
Acute Lung Injury
10%
Acute Respiratory Distress Syndrome
22%
Acute Respiratory Failure
24%
All Cause Mortality
18%
Artificial Respiration
32%
Bioelectrical Impedance Analysis
10%
Biological Marker
50%
Chronic Obstructive Pulmonary Disease
12%
Cohort Analysis
45%
Community Acquired Infection
10%
Emergency Department
10%
Fluid Balance
22%
Furosemide
30%
Hazard Ratio
20%
Heart Muscle Injury
18%
Hypervolemia
54%
Hypophosphatemia
10%
Immunoassay
10%
Induced Hypothermia
20%
Infection
17%
Intensive Care
71%
Intensive Care Unit
54%
Intermediate Care
10%
Kidney Function
11%
Loop Diuretic Agent
11%
Lung Injury
20%
Meta-Analysis
23%
N(g),n(g) Dimethylarginine
20%
Neutrophil Gelatinase Associated Lipocalin
12%
Noncardiac Surgery
20%
Observational Study
12%
Patient Referral
10%
Phenotype
10%
Placebo
43%
Platelet Endothelial Cell Adhesion Molecule 1
15%
Randomized Clinical Trial
25%
Reproducibility
10%
Respiratory Failure
21%
Restylane
20%
Risk Stratification
10%
Sepsis
45%
Septic Shock
44%
Sequential Analysis
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Surfactant Protein D
10%
Syndecan 1
13%
Systematic Review
32%
Thrombomodulin
24%
Troponin
10%
Nursing and Health Professions
6 N,n' Dimethylarginine
10%
Actin
10%
Acute Kidney Failure
21%
Acute Lung Injury
10%
Adverse Event
6%
All Cause Mortality
6%
APACHE
5%
Artificial Respiration
6%
Biological Marker
13%
Bloodstream Infection
10%
C Reactive Protein
10%
Confidence Interval
18%
Creatinine
6%
Critical Illness
11%
Drug Therapy
5%
Edetic Acid
6%
Furosemide
30%
Gelsolin
10%
Gold Standard
6%
Hazard Ratio
5%
Heart Muscle Injury
8%
Heart Surgery
10%
Hypervolemia
40%
Hypophosphatemia
10%
Hypothermia
5%
Induced Hypothermia
20%
Infection
8%
Intensive Care
54%
Intensive Care Unit
51%
Loop Diuretic Agent
11%
Medline
5%
Meta Analysis
30%
N(g),n(g) Dimethylarginine
10%
Neutrophil Gelatinase Associated Lipocalin
12%
Open-Label Trial
10%
Placebo
33%
Procalcitonin
18%
Randomization
9%
Reproducibility
10%
Respiratory Failure
30%
Septic Shock
20%
Sequential Analysis
10%
Severe Acute Respiratory Syndrome
10%
Systematic Review
42%
Troponin
10%
Ventilator-Associated Pneumonia
10%
